Leveljump HealthcareJMPHF Return-on-Tangible-Equity is 0.00% as of Sep. 2025. The stock has 2 warning signs investors should review. Among 192 Medical Diagnostics & Research companies, Leveljump Healthcare ranks better than 99.48% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Leveljump Healthcare's annualized net income for the quarter that ended in Sep. 2025 was $-0.08 Mil. Leveljump Healthcare's average shareholder tangible equity for the quarter that ended in Sep. 2025 was $-2.57 Mil. Therefore, Leveljump Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2025 was N/A%.
The historical rank and industry rank for Leveljump Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
JMPHF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -205.06 Med: -85.43 Max: 17.64
Current: Negative Tangible Equity
During the past 6 years, Leveljump Healthcare's highest Return-on-Tangible-Equity was 17.64%. The lowest was -205.06%. And the median was -85.43%.
JMPHF's Return-on-Tangible-Equity is ranked better than 99.48% of 192
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.405
vs JMPHF: Negative Tangible Equity
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Leveljump Healthcare Return-on-Tangible-Equity Related Terms
Leveljump Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Leveljump Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMPHF vs TMO, DHR, IDXX: Return-on-Tangible-Equity Comparison
For the Diagnostics & Research subindustry, Leveljump Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leveljump Healthcare Return-on-Tangible-Equity vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Leveljump Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Sep. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Leveljump Healthcare (JMPHF) has a Return-on-Tangible-Equity of 0.00% as of Sep. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Leveljump Healthcare and its competitors. According to the industry distribution chart, Leveljump Healthcare ranks #1 out of 192 companies in the Medical Diagnostics & Research industry, placing it in the top 0.5%.
Is Leveljump Healthcare's Return-on-Tangible-Equity too high?
Leveljump Healthcare's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Leveljump Healthcare ranks #1 out of 192 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Leveljump Healthcare's Return-on-Tangible-Equity compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #1 out of 192 companies for Return-on-Tangible-Equity. This places Leveljump Healthcare in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Equity depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Leveljump Healthcare and its competitors. Leveljump Healthcare's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current Return-on-Tangible-Equity of 0.00%. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current Return-on-Tangible-Equity is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMPHF has been successfully added to your 